Mate Caffeoyl.

Mate's caffeine blocks adenosine receptors while theanine raises alpha wave activity and moderates the stimulation. They are combined because they act on the same arousal state from opposite sides.

Ilex paraguariensis leaf carries caffeine alongside its caffeoylquinic acids. Isolated caffeine in the same formula adds to that load at the same receptor.

Mate's caffeine slows phosphodiesterase breakdown of cyclic AMP while green tea catechins slow catechol-O-methyltransferase. Two consecutive breakdown steps blocked keeps adrenergic signalling up longer.

Guarana is a second caffeine-bearing botanical, so the two stack on the same receptor. Their tannin and polyphenol fractions also add on mineral binding in the gut.

Caffeoylquinic acids and tannins in mate leaf form insoluble complexes with non-heme iron in the gut lumen. Co-dosing cuts iron uptake substantially, so the two belong a couple of hours apart.

Ascorbate keeps iron in the ferrous state and competes with polyphenol binding in the gut lumen. Including it partly offsets the mineral binding that mate's caffeoyl compounds cause.

The same phenolic fraction that binds iron also complexes zinc and other divalent cations. Separating the doses protects what is absorbed.

Caffeine produces a modest rise in urinary calcium excretion. Calcium beside a caffeine botanical offsets that loss rather than producing a joint action.

Adenosine build-up is part of the drive toward sleep and caffeine blocks its receptor. Taken near a melatonin dose the two work against each other.

Tyrosine is the substrate for dopamine and noradrenaline synthesis. Under the adrenergic drive caffeine amplifies, precursor supply becomes the limiting step.

Caffeoyl esters and related polyphenols form insoluble complexes with ferrous and ferric iron in the gut lumen, which lowers non-heme iron uptake when both are taken together. Mate infusions and extracts are polyphenol-rich enough for this to matter at a meal. Spacing an iron dose away from the extract is the ordinary handling.

Amino acid chelated iron is less exposed to luminal polyphenol binding because the glycine ligands occupy coordination sites, but the interaction is not abolished. Taking a polyphenol-rich extract with any non-heme iron source still shifts absorption. This is stated as a handling difference, not a reason to prefer one iron form.

Mate leaf carries caffeine alongside its caffeoyl derivatives, so an added anhydrous caffeine dose stacks on top of the plant's own. Total daily caffeine, not the number of ingredients, is what determines the response and the tolerance ceiling. Label the combined amount rather than each source separately.

Taurine appears with caffeine sources in energy formulations, where it is included for its own osmolyte and calcium-handling roles rather than as a stimulant. It does not add caffeine. The pairing is formulation practice with little combination evidence specific to mate.

Rhodiola rosavins and salidroside act on monoamine handling and stress signalling, while mate delivers caffeine and adenosine receptor antagonism. Effects on alertness can add without sharing a pathway. Anyone sensitive to stimulation should count both.

Caffeoyl phenolics are oxidised to radicals as they scavenge, and thiol systems including the lipoate and glutathione couple regenerate the reduced form. That regeneration is what makes a phenolic act more than once. The chemistry is established; effects on any clinical endpoint are not.

Tocopheroxyl radicals in the membrane are reduced back by aqueous-phase reductants including ascorbate and plant phenolics. Caffeoyl derivatives sit in the aqueous phase, so they can participate in that recycling. This is redox chemistry rather than an outcome in people.

Quercetin and caffeoylquinic acids are handled by the same UGT, SULT and COMT enzymes and the same efflux pumps in the enterocyte. Large simultaneous doses compete for that capacity, which changes exposure to both in ways that are hard to predict from either alone. Note it when stacking polyphenol extracts.

Caffeoylquinic acids slow carbohydrate digestion by inhibiting alpha-glucosidase and alpha-amylase in the gut lumen, while chromium acts on insulin signalling inside the cell. Effects on post-meal glucose, which is a marker rather than a clinical outcome, can therefore add. Anyone already managing blood sugar with medical support should account for the combination.

Berberine acts on AMPK signalling and gut microbial metabolism, while caffeoyl esters act on luminal carbohydrate-digesting enzymes. The two may add on post-meal glucose, which is a marker and not a clinical outcome, and no trial of the pair sits in this candidate set. That possible additivity is the reason to flag it, not a benefit claim.

Cinnamon polyphenols and mate caffeoylquinic acids both slow starch breakdown in the gut lumen. The effects are measured as post-meal glucose markers, which are markers and not clinical outcomes. Additive by mechanism, untested as a pair here.

Deoxynojirimycin is a competitive alpha-glucosidase inhibitor and caffeoylquinic acids inhibit the same brush border enzymes less potently. Together the inhibition adds, which also means gastrointestinal gas and fullness can add. A dose-finding pairing rather than a straightforward stack.

Gymnemic acids act at sweet taste and intestinal glucose handling, mate caffeoyl esters at luminal digestive enzymes. Both sit in the same product category with distinct mechanisms. Formulation-level pairing with no combination trial in this candidate set.

Carnitine carries long-chain fatty acids across the mitochondrial membrane, while caffeine from mate raises catecholamine-driven lipolysis. The two act at different steps of the same fuel route. The pairing is common in products and thin on combination evidence.

Caffeine produces a modest short-term rise in urinary output and mineral loss, magnesium included. In habitual users the effect is small. It is a reason to keep mineral intake steady, not a warning about the extract.

Caffeine-containing infusions increase urine volume modestly, and potassium is one of the electrolytes carried out with it. Ordinary dietary intake covers the difference in most people. Listed for completeness in electrolyte formulation work.

Most chlorogenic acid escapes small intestinal absorption and is hydrolysed by bacterial esterases in the colon to caffeic and quinic acid, then further to phenolic metabolites that do get absorbed. The gut community therefore determines much of the exposure. Which strains matter is not established.

Colonic esterase activity comes from the resident bacterial community, and fermentable fibre feeds it. That is a plausible route to more phenolic metabolite formation from a caffeoyl-rich extract. Plausible from mechanism, unquantified.

Both extracts contribute caffeine and both contribute polyphenols handled by the same conjugation enzymes, so a combined product raises total caffeine and competes for the same phase II capacity. The practical consequence is total-caffeine accounting and possible gastric discomfort at higher doses. Not a new mechanism, a larger dose of the same ones.

Carotenoid absorption needs dietary fat and micelle formation, and an aqueous polyphenol extract contributes none. Where a mate extract replaces a meal component, the carotenoid in that meal is absorbed less well. A delivery observation, not an interaction between the compounds themselves.